๐๏ธ Verified NIH Record โข Updated 2026-07-28
Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers (NCT05891171)
A Phase 1/1b Study to Evaluate the Safety and Tolerability of AB598 Monotherapy and Combination Therapy in Participants With Advanced Malignancies
๐ต Active, Not Recruiting Phase1 ๐ Investigational Drug / Biologic Sponsor: Arcus Biosciences, Inc.
๐ฉบ Plain-English Summary (8th-Grade Level)
The primary purpose of this study is to assess the safety and tolerability of AB598 in participants with advanced malignancies.
Who can join: Review the eligibility criteria below.
Location: Research Site โ Phoenix, Arizona
Age range: 18 Years
๐งช Interventions in This Study
๐ "Do I Qualify?" โ 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria โ
๐ All Participating Trial Locations (14 Sites)
- Research Site โ Phoenix, Arizona
- Research Site โ Jacksonville, Florida
- Research Site โ Lake City, Florida
- Research Site โ Hinsdale, Illinois
- Research Site โ Detroit, Michigan
- Research Site โ Rochester, Minnesota
- Research Site โ New Brunswick, New Jersey
- Research Site โ Canton, Ohio
- Research Site โ Cleveland, Ohio
- Research Site โ Irving, Texas
- Research Site โ Fairfax, Virginia
- Research Site โ Adelaide,
- Research Site โ Tainan,
- Research Site โ Taipei,
๐ฐ Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA ยง 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Advanced Cancer
- Intrapleural Catheter Daily Versus Three Times a Week Drainage โ Houston, Texas
- Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer โ Toronto, Ontario
- Meaning-Centered Intervention for Muslim Patients Who Are Being Treated for Advanced Cancer โ New York, New York
- FS120 Phase 1/1b Study in Patients With Advanced Malignancies โ New Haven, Connecticut
- First-in-Human Study of OKI-219 in Advanced Solid Tumors and Advanced Breast Cancer โ Encinitas, California
- Trial of Two Adagrasib Dosing Regimens in NSCLC With KRAS G12C Mutation (KRYSTAL 21) โ Santa Rosa, California
Explore by condition: All Advanced Cancer clinical trials
๐ก How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.